U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 779

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:47639566-47639568
GRCh38:
Chr2:47412427-47412429
MSH2Lynch syndrome 1Likely pathogenic
(Jun 2, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr2:47705489-47705495
GRCh38:
Chr2:47478350-47478356
MSH2W312fs, W465fs, W624fs, W698fs, W714fs, W744fs, W753fs, W764fs, W777fsLynch syndrome 1Likely pathogenic
(Apr 4, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr2:47655013-47657819
GRCh38:
Chr2:47427874-47430680
MSH2Lynch syndrome 1Pathogenic
(Feb 23, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr2:47703542-47703545
GRCh38:
Chr2:47476403-47476406
MSH2Lynch syndrome 1Likely pathogenic
(Jun 12, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr2:47657050-47657051
GRCh38:
Chr2:47429911-47429912
MSH2N117fs, N276fs, N350fs, N366fs, N396fs, N405fs, N416fsLynch syndrome 1Pathogenic
(Feb 14, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr2:47693945-47693949
GRCh38:
Chr2:47466806-47466810
MSH2Lynch syndrome 1Likely pathogenic
(Mar 16, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr2:47637505-47637511
GRCh38:
Chr2:47410366-47410372
MSH2Lynch syndrome 1Likely pathogenic
(Jul 7, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr2:47482114-47665324
BCYRN1, EPCAM, MSH2Lynch syndrome 1Pathogenic
(May 26, 2023)
no assertion criteria provided
9.
GRCh37:
Chr2:47526868-47665324
BCYRN1, EPCAM, MSH2Lynch syndrome 1Pathogenic
(May 26, 2023)
no assertion criteria provided
10.
GRCh37:
Chr3:37092000-37092001
GRCh38:
Chr3:37050509-37050510
MLH1S353*, S370*, S470*, S613*, S642*, S656*, S678*, S680*, S711*Lynch syndrome 1Likely pathogenicno assertion criteria provided
11.
GRCh37:
Chr3:37067255
GRCh38:
Chr3:37025764
MLH1E149fs, E292fs, E32fs, E357fs, E390fs, E49fsLynch syndrome 1Likely pathogenicno assertion criteria provided
12.
GRCh37:
Chr2:47690170-47708011
MSH2Lynch syndrome 1Likely pathogenicno assertion criteria provided
13.
GRCh37:
Chr2:47702343-47702344
GRCh38:
Chr2:47475204-47475205
MSH2I196fs, I349fs, I508fs, I582fs, I598fs, I628fs, I637fs, I648fs, I661fsLynch syndrome 1Likely pathogenicno assertion criteria provided
14.
GRCh38:
Chr2:47614711-47657080
MSH2Lynch syndrome 1Likely pathogenicno assertion criteria provided
15.
GRCh38:
Chr2:47612305-47643568
MSH2Lynch syndrome 1Likely pathogenicno assertion criteria provided
16.
GRCh37:
Chr2:48032129-48032130
GRCh38:
Chr2:47804990-47804991
MSH6T1000fs, T102fs, T1045fs, T1076fs, T1117fs, T1119fs, T1149fs, T1175fs, T1177fs, T1207fs, T124fs, T490fs, T653fs, T873fs, T887fsLynch syndrome 1Likely pathogenicno assertion criteria provided
17.
GRCh37:
Chr2:48027119-48027120
GRCh38:
Chr2:47799980-47799981
MSH6D365*, D492*, D537*, D568*, D611*, D641*, D667*, D669*, D699*Lynch syndrome 1Likely pathogenicno assertion criteria provided
18.
GRCh37:
Chr7:6026730
GRCh38:
Chr7:5987099
PMS2E245fs, E299fs, E365fs, E369fs, E385fs, E398fs, E401fs, E421fs, E434fs, E444fs, E448fs, E450fs, E453fs, E490fs, E500fs, E504fs, E520fs, E556fs, E564fs, E618fsLynch syndrome 1Likely pathogenicno assertion criteria provided
19.
GRCh37:
Chr2:48027430
GRCh38:
Chr2:47800291
MSH6D770Y, G468C, G595C, G640C, G671C, G714C, G744C, G770C, G772C, G802CLynch syndrome 1Likely pathogenicno assertion criteria provided
20.
GRCh37:
Chr2:47470308-47807597
BCYRN1, EPCAM, KCNK12, MSH2, MSH2-OT1Lynch syndrome 1Pathogenic
(Jun 22, 2022)
no assertion criteria provided
21.
GRCh37:
Chr2:47643536
GRCh38:
Chr2:47416397
MSH2Q328H, Q337H, Q348H, Q49H, Q298H, Q208H, Q282HHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Uncertain significance
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr2:47635594-47635595
GRCh38:
Chr2:47408455-47408456
MSH2K90fs, K24fsHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Pathogenic
(Feb 7, 2023)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr3:37059085
GRCh38:
Chr3:37017594
MLH1Y195*, Y260*, Y293*, Y52*Lynch syndrome 1, Hereditary nonpolyposis colorectal carcinomaLikely pathogenic
(Oct 27, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr2:47702211
GRCh38:
Chr2:47475072
MSH2D304Y, D463Y, D537Y, D553Y, D151Y, D592Y, D583Y, D603Y, D616YHereditary cancer-predisposing syndrome, Lynch syndrome 1Likely pathogenic
(Mar 21, 2023)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr2:47643444
GRCh38:
Chr2:47416305
MSH2E268*, E19*, E318*, E178*, E298*, E307*, E252*Hereditary cancer-predisposing syndrome, Lynch syndrome 1Pathogenic
(Dec 9, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr2:47639638
GRCh38:
Chr2:47412499
MSH2L104*, L244*, L178*, L224*Lynch syndrome 1, Hereditary cancer-predisposing syndromePathogenic
(Feb 15, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr7:5876369-6122058
AIMP2, CCZ1, EIF2AK1, OCM, PMS2, RSPH10BLynch syndrome 1Pathogenic
(Nov 8, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:47657062-47657063
GRCh38:
Chr2:47429923-47429924
MSH2A354fs, A420fsLynch syndrome 1Pathogenic
(Oct 19, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr2:47656941-47656942
GRCh38:
Chr2:47429802-47429803
MSH2P319fs, P385fsLynch syndrome 1Pathogenic
(Sep 8, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr2:47637390
GRCh38:
Chr2:47410251
MSH2L109fs, L175fsLynch syndrome 1Likely pathogenic
(Jun 3, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr7:6029692-6029693
GRCh38:
Chr7:5990061-5990062
PMS2Lynch syndrome 1Uncertain significancecriteria provided, single submitter
32.
GRCh37:
Chr2:47656968-47656969
GRCh38:
Chr2:47429829-47429830
MSH2Lynch syndrome 1Pathogenicno assertion criteria provided
33.
GRCh37:
Chr22:29091768
GRCh38:
Chr22:28695780
CHEK2V176fs, V330fs, V440fs, V397fs, V368fsLynch syndrome 1Likely pathogenicno assertion criteria provided
34.
GRCh37:
Chr3:37035130
GRCh38:
Chr3:36993639
MLH1A31DHereditary cancer-predisposing syndromeUncertain significance
(Sep 9, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr2:47613709-47613710
GRCh38:
Chr2:47386570-47386571
EPCAMLynch syndrome 1Likely pathogenic
(Jun 3, 2022)
no assertion criteria provided
36.
GRCh37:
Chr11:108099920
GRCh38:
Chr11:108229193
ATMY67*Lynch syndrome 1Likely pathogenic
(Jul 14, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr16:23619220-23619221
GRCh38:
Chr16:23607899-23607900
PALB2V1105fsLynch syndrome 1Likely pathogenic
(Nov 16, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr2:47639611
GRCh38:
Chr2:47412472
MSH2K169T, K235THereditary cancer-predisposing syndrome, Lynch syndrome 1Uncertain significance
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr2:47690211
GRCh38:
Chr2:47463072
MSH2N411fs, N477fsLynch syndrome 1Pathogenic
(Jun 9, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr2:47705487
GRCh38:
Chr2:47478348
MSH2A697P, A763PLynch syndrome 1Pathogenic
(May 4, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr2:47693796
GRCh38:
Chr2:47466657
MSH2Hereditary cancer-predisposing syndrome, Lynch syndrome 1Pathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr2:47703680-47703681
GRCh38:
Chr2:47476541-47476542
MSH2E662*, E728*Lynch syndrome 1Likely pathogenic
(Jul 13, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr2:47630444
GRCh38:
Chr2:47403305
MSH2D38EHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Conflicting interpretations of pathogenicity
(May 5, 2023)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr2:47643435
GRCh38:
Chr2:47416296
MSH2G249C, G315CMismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:47672691-47672692
GRCh38:
Chr2:47445552-47445553
MSH2H362fs, H428fsHereditary nonpolyposis colorectal neoplasmsPathogenic
(Jul 11, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr2:47643553
GRCh38:
Chr2:47416414
MSH2N288S, N354SHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Hereditary cancer-predisposing syndrome
Uncertain significance
(Aug 4, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr2:47641532-47641535
GRCh38:
Chr2:47414393-47414396
MSH2V241fs, V307fsHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Pathogenic
(Jan 11, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr2:48033499
GRCh38:
Chr2:47806360
MSH6Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Likely pathogenic
(Jul 28, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr3:37035093-37035101
GRCh38:
Chr3:36993602-36993610
MLH1I19fsLynch syndrome 1Pathogeniccriteria provided, single submitter
50.
GRCh37:
Chr2:47630479
GRCh38:
Chr2:47403340
MSH2A50VLynch syndrome 1, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Sep 13, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr2:47703685-47703692
GRCh38:
Chr2:47476546-47476553
MSH2M663fs, M729fsLynch syndrome 1not providedno assertion provided
52.
GRCh37:
Chr3:37086066-37089603
GRCh38:
Chr3:37044575-37048112
MLH1Colorectal cancer, hereditary nonpolyposis, type 2Pathogenic
(Dec 1, 1996)
no assertion criteria provided
53.
GRCh37:
Chr2:47610875-47615785
GRCh38:
Chr2:47383736-47388646
EPCAMLynch syndrome 1not providedno assertion provided
54.
GRCh37:
Chr2:47706634
GRCh38:
Chr2:47479495
MSH2Hereditary cancer-predisposing syndromeLikely pathogenic
(Apr 6, 2022)
criteria provided, single submitter
55.
MSH2Lynch syndrome 1Pathogenic
(Sep 30, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr2:47637343-47637344
GRCh38:
Chr2:47410204-47410205
MSH2Q160fs, Q94fsnot provided, Lynch syndrome 1Pathogenic
(Jan 6, 2023)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr2:48032171-48032174
GRCh38:
Chr2:47805032-47805035
MSH6Lynch syndrome 1, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 14, 2020)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr2:47702166-47702167
GRCh38:
Chr2:47475027-47475028
MSH2Y522fs, Y588fsLynch syndrome 1Likely pathogenic
(Apr 2, 2020)
criteria provided, single submitter
59.
GRCh37:
Chr3:37061918
GRCh38:
Chr3:37020427
MLH1L237fs, L302fs, L335fs, L94fsLynch syndrome 1, Hereditary cancer-predisposing syndromePathogenic
(Apr 2, 2020)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr2:47702303
GRCh38:
Chr2:47475164
MSH2Lynch syndrome 1, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Mar 26, 2023)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr2:47698181
GRCh38:
Chr2:47471042
MSH2I515fs, I581fsLynch syndrome 1, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Feb 7, 2023)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr2:47705644
GRCh38:
Chr2:47478505
MSH2Y749C, Y815CHereditary nonpolyposis colorectal neoplasms, not provided, Lynch syndrome 1
Uncertain significance
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr3:37061894-37061896
GRCh38:
Chr3:37020403-37020405
MLH1Q230del, Q295del, Q328del, Q87delLynch syndrome 1Likely pathogenic
(Mar 29, 2020)
criteria provided, single submitter
64.
GRCh37:
Chr2:47705566
GRCh38:
Chr2:47478427
MSH2L724fs, L790fsHereditary cancer-predisposing syndrome, Lynch syndrome 1Pathogenic/Likely pathogenic
(Jul 6, 2021)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr2:47635665
GRCh38:
Chr2:47408526
MSH2K113*, K47*Lynch syndrome 1Pathogenic
(Sep 23, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr2:47672686
GRCh38:
Chr2:47445547
MSH2Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasmsPathogenic/Likely pathogenic
(Jan 11, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr2:47702396
GRCh38:
Chr2:47475257
MSH2H665fs, H599fsLynch syndrome 1, Hereditary nonpolyposis colorectal neoplasmsPathogenic
(Jan 5, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr2:190682764
GRCh38:
Chr2:189818038
PMS1R86K, R147KLynch syndrome 1Uncertain significance
(Mar 27, 2020)
criteria provided, single submitter
69.
GRCh37:
Chr2:47630503-47630504
GRCh38:
Chr2:47403364-47403365
MSH2K59fsHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
Pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr2:47702412
GRCh38:
Chr2:47475273
MSH2Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Uncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr2:47637504
GRCh38:
Chr2:47410365
MSH2L147R, L213RLynch syndrome 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr2:47710152
GRCh38:
Chr2:47483013
MSH2Lynch syndrome 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr2:47710135
GRCh38:
Chr2:47482996
MSH2Lynch syndrome 1, not specifiedConflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:47637428
GRCh38:
Chr2:47410289
MSH2E122K, E188KHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1Uncertain significance
(Dec 14, 2021)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr2:47709894
GRCh38:
Chr2:47482755
MSH2Hereditary cancer-predisposing syndrome, Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms
Pathogenic/Likely pathogenic
(Jun 5, 2023)
criteria provided, multiple submitters, no conflicts
76.
MLH1Lynch syndrome 1Likely pathogenicno assertion criteria provided
77.
MLH1Lynch syndrome 1Pathogenicno assertion criteria provided
78.
MLH1Lynch syndrome 1Pathogenicno assertion criteria provided
79.
GRCh37:
Chr3:37090036-37090037
GRCh38:
Chr3:37048545-37048546
MLH1I285fs, I402fs, I588fs, I545fs, I302fs, I643fs, I610fsLynch syndrome 1Likely pathogenicno assertion criteria provided
80.
GRCh37:
Chr3:37090446
GRCh38:
Chr3:37048955
MLH1A583fs, A650fs, A323fs, A440fs, A340fs, A626fs, A648fs, A681fsLynch syndrome 1Likely pathogenicno assertion criteria provided
81.
GRCh37:
Chr3:37061799
GRCh38:
Chr3:37020308
MLH1Lynch syndrome 1Likely pathogenicno assertion criteria provided
82.
GRCh37:
Chr3:37090485
GRCh38:
Chr3:37048994
MLH1E453*, E596*, E661*, E694*, E639*, E336*, E353*, E663*Hereditary cancer-predisposing syndrome, not providedPathogenic
(Apr 1, 2023)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr3:37067225-37067235
GRCh38:
Chr3:37025734-37025744
MLH1A282fs, A39fs, A139fs, A22fs, A347fs, A380fsLynch syndrome 1Likely pathogenicno assertion criteria provided
84.
GRCh37:
Chr3:37081734-37081737
GRCh38:
Chr3:37040243-37040246
MLH1A506fs, A181fs, A198fs, A298fs, A539fs, A441fsLynch syndrome 1Likely pathogenicno assertion criteria provided
85.
GRCh37:
Chr3:37081730
GRCh38:
Chr3:37040239
MLH1W440fs, W197fs, W505fs, W180fs, W297fs, W538fsLynch syndrome 1Likely pathogenicno assertion criteria provided
86.
GRCh37:
Chr2:47606980
GRCh38:
Chr2:47379841
EPCAMP244ALynch syndrome 1Uncertain significanceno assertion criteria provided
87.
GRCh37:
Chr3:37050323
GRCh38:
Chr3:37008832
MLH1N60fs, N125fs, N158fsHereditary cancer-predisposing syndromePathogenic
(Jun 13, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr2:47612354
GRCh38:
Chr2:47385215
EPCAMLynch syndrome 1Uncertain significanceno assertion criteria provided
89.
GRCh37:
Chr2:47643576
GRCh38:
Chr2:47416437
MSH2Lynch syndrome 1Uncertain significanceno assertion criteria provided
90.
GRCh37:
Chr3:37090388-37090402
GRCh38:
Chr3:37048897-37048911
MLH1Lynch syndrome 1Likely pathogenicno assertion criteria provided
91.
GRCh37:
Chr2:48026625
GRCh38:
Chr2:47799486
MSH6H371Q, H501Q, H199QLynch syndrome 1Uncertain significanceno assertion criteria provided
92.
GRCh37:
Chr3:37045930-37045934
GRCh38:
Chr3:37004439-37004443
MLH1T18fs, T116fs, T83fsLynch syndrome 1Likely pathogenic
(May 1, 2018)
no assertion criteria provided
93.
GRCh37:
Chr3:37035042
GRCh38:
Chr3:36993551
MLH1S2AHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndromeUncertain significance
(Jul 2, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr2:47698130
GRCh38:
Chr2:47470991
MSH2Y497C, Y563CHereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Lynch syndrome 1,
Mismatch repair cancer syndrome 2, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr2:47705549
GRCh38:
Chr2:47478410
MSH2H719fs, H785fsHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
Pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr2:47710038-47710040
GRCh38:
Chr2:47482899-47482901
MSH2N854del, N920delHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndromeUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr2:47703565
GRCh38:
Chr2:47476426
MSH2A623T, A689THereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Mar 20, 2023)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr3:37067319-37067321
GRCh38:
Chr3:37025828-37025830
MLH1I378fs, I411fs, I53fs, I313fs, I70fs, I170fsHereditary cancer-predisposing syndromePathogenic
(Apr 11, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr2:47739658
GRCh38:
Chr2:47512519
KCNK12, MSH2Lynch syndrome 1Likely benign
(May 28, 2019)
criteria provided, single submitter
100.
GRCh37:
Chr2:47739521
GRCh38:
Chr2:47512382
KCNK12, MSH2Lynch syndrome 1Uncertain significance
(May 28, 2019)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination